Antitumor antineoplastic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Cell Line, Tumor Tumor Cells, Cultured HL-60 Cells Cell Line Cells, Cultured HT29 Cells T-Lymphocytes, Cytotoxic CD8-Positive T-Lymphocytes Dendritic Cells Killer Cells, Natural T-Lymphocytes Lymphocytes, Tumor-Infiltrating K562 Cells

Organisms12

Narcissus Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Aster Plant Olacaceae Mice, Inbred DBA Oncolytic Viruses Adenoviridae Streptomyces Mice, Inbred Strains

Diseases35

Leukemia P388 Neoplasms Sarcoma 180 Leukemia L1210 Neoplasms, Experimental Lung Neoplasms Colonic Neoplasms Breast Neoplasms Ovarian Neoplasms Melanoma, Experimental Leukemia Prostatic Neoplasms Carcinoma, Ehrlich Tumor Melanoma Mammary Neoplasms, Experimental Neovascularization, Pathologic Carcinoma, Lewis Lung Sarcoma, Experimental Fibrosarcoma Leukemia, Experimental Adenocarcinoma Lymphoma Neoplasm Metastasis Brain Neoplasms Phlebitis Glioma Kidney Neoplasms Disease Models, Animal Liver Neoplasms Carcinoma, Renal Cell Liver Neoplasms, Experimental Colorectal Neoplasms Multiple Myeloma Pancreatic Neoplasms Carcinoma, Squamous Cell

Chemicals and Drugs115

Antineoplastic Agents Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Ellipticines Amaryllidaceae Alkaloids Doxorubicin Bibenzyls Antineoplastic Agents, Alkylating Bryostatins Thiadiazines Ancitabine Cisplatin Gallium Depsipeptides Paclitaxel Aminoacridines 6-Mercaptopurine Epothilones Lactones Fluorouracil Antimetabolites, Antineoplastic Daunorubicin Prodrugs Bleomycin Etoposide Camptothecin Macrolides Enzyme Inhibitors Methotrexate Stilbenes Isoquinolines Cyclophosphamide Vincristine Taxoids Caspases DNA Phospholipid Ethers RNA, Messenger Cancer Vaccines Reactive Oxygen Species Amsacrine Antibodies, Monoclonal Antigens, Neoplasm Angiogenesis Inhibitors Enediynes Topoisomerase I Inhibitors Topoisomerase II Inhibitors Sulindac Intercalating Agents Nitrogen Mustard Compounds Mitomycin Thiosemicarbazones Dioxoles Plant Extracts Floxuridine Pyrazines Carmustine Drug Carriers Pyrroles Mitomycins Protein Kinase Inhibitors Pyrones Alkaloids Farnesyltranstransferase Benzoquinones Organoplatinum Compounds Vanadium Compounds Deoxycytidine DNA Topoisomerases, Type II DNA, Neoplasm Sulfonamides DNA Adducts Topotecan Cytarabine Boronic Acids Histone Deacetylase Inhibitors Nitrosourea Compounds Immunotoxins Antibodies, Monoclonal, Humanized Hazardous Substances Tubulin Modulators Liposomes Neoplasm Proteins Thiazoles Recombinant Proteins Tetrahydroisoquinolines Drugs, Investigational Interferon-gamma Interleukin-2 2-Propanol Alkylating Agents Caspase 3 Hydrazones Vinblastine Razoxane Suramin Interleukin-12 Pyridines Anthracyclines Piperazines Naphthacenes Proto-Oncogene Proteins c-bcl-2 Hydroxamic Acids Sesquiterpenes Growth Inhibitors DNA Topoisomerases, Type I Indoles Azacitidine Isocoumarins Pyrimidines Dacarbazine Thymidylate Synthase P-Glycoprotein Peptides, Cyclic Zinostatin

Analytical, Diagnostic and Therapeutic Techniques and Equipment44

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Neoplasms, Experimental Neoplasm Transplantation Antineoplastic Combined Chemotherapy Protocols Drug Evaluation, Preclinical Drug Evaluation Drug Administration Schedule Melanoma, Experimental Clinical Trials as Topic Inhibitory Concentration 50 Treatment Outcome Immunotherapy Transplantation, Heterologous Gloves, Protective Immunotherapy, Adoptive Tumor Burden Genetic Therapy Mammary Neoplasms, Experimental Flow Cytometry Tumor Stem Cell Assay Injections, Intralesional Protective Devices Oncolytic Virotherapy Sarcoma, Experimental Blotting, Western Equipment and Supplies, Hospital Protective Clothing Leukemia, Experimental Lethal Dose 50 Drug Carriers Combined Modality Therapy Injections, Intraperitoneal Drug Delivery Systems Transfection Antineoplastic Protocols Drug Compounding Comet Assay Disease Models, Animal Administration, Oral Infusions, Intravenous Liver Neoplasms, Experimental Magnetic Resonance Spectroscopy Drug Design

Phenomena and Processes32

Drug Synergism Apoptosis Cell Survival Molecular Structure Dose-Response Relationship, Drug Cell Division Drug Resistance, Neoplasm Cell Proliferation Cell Cycle Drug Resistance Time Factors Biotransformation Drug Interactions Stereoisomerism DNA Damage Structure-Activity Relationship Kinetics Inhibitory Concentration 50 Dental Physiological Processes Cytotoxicity, Immunologic Gene Expression Regulation, Neoplastic Lethal Dose 50 Genetic Vectors Signal Transduction Drug Resistance, Multiple Transfection DNA Adducts Cell Growth Processes Cell Death Tissue Distribution Phosphorylation Tumor Escape

Disciplines and Occupations2

Oncology Nursing Drug Design

Technology, Industry, Agriculture5

Gloves, Protective Laundering Protective Devices Protective Clothing Liposomes

Information Science1

Molecular Sequence Data

Named Groups3

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital

Health Care13

Clinical Trials as Topic Treatment Outcome Occupational Exposure Medical Secretaries Oncology Nursing Equipment Contamination Decontamination Antineoplastic Protocols Nursing Staff, Hospital Environmental Monitoring Personnel, Hospital Pharmacies Oncology Service, Hospital

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Named Groups Health Care

Antineoplastic Agents Leukemia P388 Drug Screening Assays, Antitumor Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Ellipticines Amaryllidaceae Alkaloids Doxorubicin Narcissus Bibenzyls Xenograft Model Antitumor Assays Neoplasms Antineoplastic Agents, Alkylating Cell Line, Tumor Bryostatins Thiadiazines Tumor Cells, Cultured Sarcoma 180 Drug Synergism Apoptosis Ancitabine Cisplatin Gallium Depsipeptides Paclitaxel Leukemia L1210 Cell Survival Aminoacridines Molecular Structure Neoplasms, Experimental 6-Mercaptopurine Epothilones Mice, Nude Dose-Response Relationship, Drug Neoplasm Transplantation Lactones Fluorouracil Antimetabolites, Antineoplastic Daunorubicin Antineoplastic Combined Chemotherapy Protocols Cell Division Prodrugs Drug Resistance, Neoplasm Drug Evaluation, Preclinical Bleomycin Cell Proliferation Etoposide Drug Evaluation Camptothecin Lung Neoplasms Cell Cycle Drug Resistance Macrolides Drug Administration Schedule Enzyme Inhibitors Methotrexate Stilbenes HL-60 Cells Colonic Neoplasms Breast Neoplasms Time Factors Biotransformation Isoquinolines Cyclophosphamide Vincristine Ovarian Neoplasms Drug Interactions Melanoma, Experimental Cell Line Stereoisomerism DNA Damage Clinical Trials as Topic Leukemia Mice, Inbred BALB C Structure-Activity Relationship Kinetics Taxoids Prostatic Neoplasms Caspases DNA Phospholipid Ethers RNA, Messenger Cells, Cultured Cancer Vaccines Mice, Inbred C57BL Reactive Oxygen Species Inhibitory Concentration 50 Mice, SCID Treatment Outcome Immunotherapy Transplantation, Heterologous Gloves, Protective Carcinoma, Ehrlich Tumor Melanoma Immunotherapy, Adoptive Amsacrine Antibodies, Monoclonal Aster Plant Antigens, Neoplasm Tumor Burden

No FAQ available that match "antitumor antineoplastic agents"